Company profile VTVT
There is not enough data for vTv Therapeutics (VTVT) to provide analysis
There is not enough data for vTv Therapeutics (VTVT) to provide correlation calculation
There is not enough data for vTv Therapeutics (VTVT) to provide analysis
After 34 days of this quarter the interest is at 65.0. Based on that we can calculate that during remaining 58 days it will total up to 176.0. vTv Therapeutics stock expected interest is significantly higher compared to previous quarter (+183.9%) and same quarter last year (+70.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 18 |
| 2019 | 50 177.8% QoQ | 20 -60.0% QoQ | 208 940.0% QoQ | 115 538.9% YoY -44.7% QoQ |
| 2020 | 113 126.0% YoY -1.7% QoQ | 109 445.0% YoY -3.5% QoQ | 99 -52.4% YoY -9.2% QoQ | 128 11.3% YoY 29.3% QoQ |
| 2021 | 31 -72.6% YoY -75.8% QoQ | 61 -44.0% YoY 96.8% QoQ | 114 15.2% YoY 86.9% QoQ | 47 -63.3% YoY -58.8% QoQ |
| 2022 | 113 264.5% YoY 140.4% QoQ | 49 -19.7% YoY -56.6% QoQ | 50 -56.1% YoY 2.0% QoQ | 103 119.1% YoY 106.0% QoQ |
| 2023 | 54 -52.2% YoY -47.6% QoQ | 69 40.8% YoY 27.8% QoQ | 62 24.0% YoY -10.1% QoQ | 65 -36.9% YoY 4.8% QoQ |
The average 5 years interest of vTv Therapeutics stock was 6.45 per week. The last year interest of vTv Therapeutics stock compared to the last 5 years has changed by -15.97%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -9.97%.
There is not enough data for TTP399 diabetes to provide analysis
There is not enough data for TTP399 diabetes to provide correlation calculation
There is not enough data for TTP399 diabetes to provide analysis
There is not enough data for HPP737 inflammatory diseases to provide analysis
There is not enough data for HPP737 inflammatory diseases to provide correlation calculation
There is not enough data for HPP737 inflammatory diseases to provide analysis
There is not enough data for vTv Therapeutics diabetes treatment to provide analysis
There is not enough data for vTv Therapeutics diabetes treatment to provide correlation calculation
There is not enough data for vTv Therapeutics diabetes treatment to provide analysis
There is not enough data for vTv Therapeutics drug candidate to provide analysis
There is not enough data for vTv Therapeutics drug candidate to provide correlation calculation
There is not enough data for vTv Therapeutics drug candidate to provide analysis
There is not enough data for vTv Therapeutics biopharmaceutical company to provide analysis
There is not enough data for vTv Therapeutics biopharmaceutical company to provide correlation calculation
There is not enough data for vTv Therapeutics biopharmaceutical company to provide analysis
There is not enough data for vTv Therapeutics clinical-stage to provide analysis
There is not enough data for vTv Therapeutics clinical-stage to provide correlation calculation
There is not enough data for vTv Therapeutics clinical-stage to provide analysis
There is not enough data for vTv Therapeutics liver-selective glucokinase activator to provide analysis
There is not enough data for vTv Therapeutics liver-selective glucokinase activator to provide correlation calculation
There is not enough data for vTv Therapeutics liver-selective glucokinase activator to provide analysis
There is not enough data for vTv Therapeutics non-CNS penetrant PDE4 inhibitor to provide analysis
There is not enough data for vTv Therapeutics non-CNS penetrant PDE4 inhibitor to provide correlation calculation
There is not enough data for vTv Therapeutics non-CNS penetrant PDE4 inhibitor to provide analysis